Algo version: 0.98b
EMBCV is listed at the NASDAQ Exchange
EMBCV [EMBCV]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is EMBCV stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Embecta Corp. 10 years ago, but if you had invested on Tuesday 22nd of March 2022 when the price was $47.00, you would have made a loss of $-13.67 per share or -29.09%

Yes, the average daily trading liquidity for Embecta Corp. is $1.02 million. You should therefore be able to get in and out of your positions relatively fast.

Embecta Corp. has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.02, the company's ability to pay off the debt is limited. Embecta Corp. has a good net profit margin of 6.20% and should have high tolerances against inflation.

We have calculated the inflation risk for Embecta Corp. to be medium [0.7 out of 1]